These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 26478666

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
    Casey JL, Feld JJ, MacParland SA.
    Cells; 2019 Apr 05; 8(4):. PubMed ID: 30959825
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.
    Chan ST, Ou JJ.
    Viruses; 2017 Aug 12; 9(8):. PubMed ID: 28805674
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
    Puig M, Mihalik K, Tilton JC, Williams O, Merchlinsky M, Connors M, Feinstone SM, Major ME.
    Hepatology; 2006 Sep 12; 44(3):736-45. PubMed ID: 16941702
    [Abstract] [Full Text] [Related]

  • 27. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
    Smyk-Pearson S, Tester IA, Lezotte D, Sasaki AW, Lewinsohn DM, Rosen HR.
    J Infect Dis; 2006 Aug 15; 194(4):454-63. PubMed ID: 16845628
    [Abstract] [Full Text] [Related]

  • 28. Insights into antiviral innate immunity revealed by studying hepatitis C virus.
    Horner SM.
    Cytokine; 2015 Aug 15; 74(2):190-7. PubMed ID: 25819428
    [Abstract] [Full Text] [Related]

  • 29. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
    Bruening J, Weigel B, Gerold G.
    J Immunol Res; 2017 Aug 15; 2017():7232361. PubMed ID: 28255563
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
    Baumert TF, Fauvelle C, Chen DY, Lauer GM.
    J Hepatol; 2014 Nov 15; 61(1 Suppl):S34-44. PubMed ID: 25443345
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis C Virus Vaccine Research: Time to Put Up or Shut Up.
    Hartlage AS, Kapoor A.
    Viruses; 2021 Aug 12; 13(8):. PubMed ID: 34452460
    [Abstract] [Full Text] [Related]

  • 34. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
    Feinstone SM, Hu DJ, Major ME.
    Clin Infect Dis; 2012 Jul 12; 55 Suppl 1():S25-32. PubMed ID: 22715210
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.
    Gastroenterology; 2007 Nov 12; 133(5):1649-59. PubMed ID: 17983809
    [Abstract] [Full Text] [Related]

  • 36. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I, Pereboev A, Silva L, Zabaleta A, Riezu-Boj JI, Bes M, Cubero M, Borras-Cuesta F, Lasarte JJ, Esteban JI, Prieto J, Sarobe P.
    Hepatology; 2011 Jul 12; 54(1):28-37. PubMed ID: 21452282
    [Abstract] [Full Text] [Related]

  • 37. Innate immunity against hepatitis C virus.
    Xu Y, Zhong J.
    Curr Opin Immunol; 2016 Oct 12; 42():98-104. PubMed ID: 27366996
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Innate immune responses to hepatitis C virus.
    Schoggins JW, Rice CM.
    Curr Top Microbiol Immunol; 2013 Oct 12; 369():219-42. PubMed ID: 23463203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.